NASDAQ: FHTXFoghorn Therapeutics Inc Stock Ownership - Who owns Foghorn Therapeutics?
Insider buying vs selling
Have Foghorn Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when FHTX insiders and whales buy or sell their stock.
FHTX Shareholders
What type of owners hold Foghorn Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Cigall Kadoch | 6.10% | 3,624,379 | $15.00M | Insider |
| Flagship Ventures Fund V General Partner LLC | 3.12% | 1,851,801 | $7.67M | Insider |
| Dhabi Investment Authority Abu | 2.07% | 1,231,081 | $5.10M | Insider |
| Adrian Gottschalk | 1.72% | 1,023,408 | $4.24M | Insider |
| Carl Decicco | 0.61% | 362,707 | $1.50M | Insider |
| Steven F. Bellon | 0.26% | 151,957 | $629.10k | Insider |
| Fanny Cavalie | 0.15% | 86,992 | $360.15k | Insider |
| Ian F. Smith | 0.12% | 72,072 | $298.38k | Insider |
| Allan Reine | 0.09% | 53,784 | $222.67k | Insider |
| Simba Gill | 0.06% | 34,061 | $141.01k | Insider |
FHTX vs Biotech Stocks
Foghorn Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.